Cdymax (India) Pharma Private Limited

Specializes in manufacturing APIs for oncology and general use.

1994 | Bangaluru, Karnataka (India) | Active
Last Updated:

Cdymax (India) Pharma Profile

Key Indicators

  • Authorised Capital ₹ 10.00 Cr
  • Paid Up Capital ₹ 8.88 Cr
  • Company Age 30 Year, 6 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 62.98 Cr
  • Satisfied Charges ₹ 66.47 Cr
  • Revenue Growth 2.28%
  • Profit Growth -102.95%
  • Ebitda -838.58%
  • Net Worth -31.48%
  • Total Assets -16.65%

About Cdymax (India) Pharma

Cdymax (India) Pharma Private Limited (CIPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 27 October 1994 and has a history of 30 years and six months. Its registered office is in Bangaluru, Karnataka, India.

The Corporate was formerly known as Acebright (India) Pharma Private Limited. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 8.88 Cr.

The company currently has active open charges totaling ₹62.98 Cr. The company has closed loans amounting to ₹66.47 Cr, as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Cdymax (India) Pharma Private Limited India is Siri Bhat as COMPANY SECRETARY. Manorama Avinash and Santosh Naik serve as directors at the Company.

Company Details

  • Location

    Bangaluru, Karnataka, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U85110KA1994PTC016472

  • Company No.

    016472

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    27 Oct 1994

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Bangalore

Industry

Pharma
Company report

Cdymax (India) Pharma Private Limited

Explore comprehensive data for Cdymax (India) Pharma Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Cdymax (India) Pharma?

Executive Team (1)

NameDesignationAppointment DateStatus
Siri Bhat Company Secretary18-Aug-2023Current

Board Members (2)

NameDesignationAppointment DateStatus
Manorama Avinash Country flag representing In Director 07-May-2011Current
Santosh Naik Country flag representing In Director 08-Jan-2024Current

Financial Performance of Cdymax (India) Pharma.

Cdymax (India) Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.28% increase. The company also saw a substantial fall in profitability, with a 102.95% decrease in profit. The company's net worth observed a substantial decline by a decrease of 31.48%.

Cdymax (India) Pharma revenue growth over time
Cdymax (India) Pharma profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
2.28%
Revenue from Operations
1.15%
Total Assets
-16.65%
Profit or Loss
-102.95%
Net Worth
-31.48%
EBITDA
-838.58%

What is the Ownership and Shareholding Structure of Cdymax (India) Pharma?

In 2023, Cdymax (India) Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹62.98 Cr

Satisfied Charges

₹66.47 Cr

Charges Breakdown by Lending Institutions

  • Hdfc Bank Limited : 45.00 Cr
  • Others : 17.98 Cr

Latest Charge Details

DateLenderAmountStatus
30 Nov 2021Others₹5.99 CrOpen
20 Aug 2020Hdfc Bank Limited₹45.00 CrOpen
03 May 2018Others₹5.00 MOpen
03 May 2018Others₹4.50 MOpen
03 May 2018Others₹6.00 MOpen

How Many Employees Work at Cdymax (India) Pharma?

Cdymax (India) Pharma has a workforce of 493 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Cdymax (India) Pharma Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Cdymax (India) Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cdymax (India) Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Cdymax (India) Pharma

Recent activity within the organization

  • Charges

    A charge registered on 19 Oct 2017 via Charge ID 100131951 with Others was fully satisfied on 20 Feb 2025.

  • Annual General Meeting

    Cdymax (India) Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Charges

    A charge registered on 13 Jun 2019 via Charge ID 100267725 with Others was fully satisfied on 25 Jun 2024.

  • Balance Sheet

    Cdymax (India) Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.

  • Director Appointment

    Santosh Datta Naik was appointed as a Director was appointed as a Director on 08 Jan 2024 & has been associated with this company since 1 year 3 months .

  • Director Appointment

    Siri Surendra Bhat was appointed as a Company Secretary was appointed as a Company Secretary on 18 Aug 2023 & has been associated with this company since 1 year 8 months .

Frequently asked questions

  • What is the Incorporation or founding date of Cdymax (India) Pharma Private Limited?

    Cdymax (India) Pharma Private Limited was incorporated on 27 Oct 1994.

  • What is authorized share capital and paid-up capital of Cdymax (India) Pharma Private Limited?

    The authorized share capital of Cdymax (India) Pharma Private Limited is ₹ 10.00 Cr and paid-up capital is ₹ 8.88 Cr.

  • Who are the current board members & directors of Cdymax (India) Pharma Private Limited?

    Currently 3 directors are associated with Cdymax (India) Pharma Private Limited.

    • Manorama Avinash
    • Santosh Datta Naik
    • Siri Surendra Bhat

  • What is the registered address of Cdymax (India) Pharma Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Cdymax (India) Pharma Private Limited is 116/117 Kiadb Indl Areajigani 2Nd Phase India, Bangalore, Karnataka, 560105.

  • What is the corporate identification number (CIN) and company number of Cdymax (India) Pharma Private Limited?

    The corporate identification number (CIN) of Cdymax (India) Pharma Private Limited is U85110KA1994PTC016472 and the company number is 016472 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Cdymax (India) Pharma Private Limited?

    The Official website of Cdymax (India) Pharma Private Limited is https://www.cdymax.in

  • What has been the recent revenue trend for Cdymax (India) Pharma Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Cdymax (India) Pharma Private Limited has risen by 2.28%.

  • How many employees does Cdymax (India) Pharma Private Limited currently have?

    As Per 2023 financial reports, 493 employees are currently employed by Cdymax (India) Pharma Private Limited.

  • What change has been observed in the net worth of Cdymax (India) Pharma Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Cdymax (India) Pharma Private Limited has experienced an downturn of -31.48%.

  • What are the total open charges for Cdymax (India) Pharma Private Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Cdymax (India) Pharma Private Limited amount to ₹ 62.98 Cr.

  • When was the last Balance Sheet of Cdymax (India) Pharma Private Limited filed with the ROC?

    The most recent Balance Sheet for Cdymax (India) Pharma Private Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on API Manufacturers